These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 4996291)

  • 21. The new oral antidiabetic drugs.
    Moss JM; Delawter DE
    Am Fam Physician; 1984 Nov; 30(5):119-21. PubMed ID: 6437197
    [No Abstract]   [Full Text] [Related]  

  • 22. [Glibenclamide: its therapeutic effect in diabetes mellitus].
    Concha E; Veit O
    Rev Med Chil; 1971 Mar; 99(3):217-9. PubMed ID: 4999506
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chlorpropamide-metformin in obese diabetic patients or with secondary response failure to sulfonylureas].
    Garcia Viveros M; Lozano Castañeda O; Quibrera Infante R; Rull JA
    Prensa Med Mex; 1969; 34(9):391-6. PubMed ID: 5378265
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of glibenclamide with other oral hypoglycaemic agents.
    Wetherill JH; Tunbridge RE
    Postgrad Med J; 1970 Dec; ():Suppl:88-91. PubMed ID: 5533304
    [No Abstract]   [Full Text] [Related]  

  • 25. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419].
    Marocco F; Patrito G
    Minerva Med; 1970 Dec; 61(97):5525-42. PubMed ID: 5494124
    [No Abstract]   [Full Text] [Related]  

  • 27. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors' Pharmacare beneficiaries.
    Sketris IS; Kephart GC; Frail DM; Skedgel C; Allen MJ
    Pharmacotherapy; 2004 Jun; 24(6):784-91. PubMed ID: 15222669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of a new hypoglycemic sulfamide: glibenclamide or HB 419].
    Plauchu M
    Lyon Med; 1969 Nov; 222(40):809-16. PubMed ID: 5383402
    [No Abstract]   [Full Text] [Related]  

  • 30. Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.
    Medina Santillán R; Reyes-García G; Mateos-García E
    Proc West Pharmacol Soc; 2002; 45():137-8. PubMed ID: 12434558
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antidiabetic drugs--application and problems, with special reference to Glibenclamide (HB419)].
    Kosaka S
    Nihon Rinsho; 1970 Mar; 28 Suppl():692-5. PubMed ID: 5430845
    [No Abstract]   [Full Text] [Related]  

  • 32. [A comparative evaluation of the hypoglycemic activity of acetyl-alpha-carnitine and chlorpropamide in experimental diabetes].
    Kim EK; Trevisani K; Trevisani M; Suslina ZA; Seĭfulla RD
    Eksp Klin Farmakol; 1994; 57(4):52-3. PubMed ID: 7950787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study of a new hypoglycemic agent: Diabiphage].
    Linquette M; Fossati P; Decoulx M
    Lille Med; 1971; 17():Suppl 3:559-65. PubMed ID: 5153015
    [No Abstract]   [Full Text] [Related]  

  • 34. Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.
    Medina Santillán R; Reyes-García G; Mateos-García E
    Proc West Pharmacol Soc; 2002; 45():139-40. PubMed ID: 12434559
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of antidiabetic agents on the increase in glycemia and insulinemia caused by refeeding in hereditarily diabetic rats.
    Ladrière L; Malaisse-Lagae F; Fuhlendorff J; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1997 Jul; 97(1):53-9. PubMed ID: 9507568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.
    Chan YM; Laffel LM
    Pediatr Diabetes; 2007 Aug; 8(4):235-8. PubMed ID: 17659066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The therapeutic efficacy of saccharoreducing preparation chlorcyclamide].
    Vorona MI; Genes SG; Grinchenko TS; Kopelovich MA; Lobanovskaia LI
    Klin Med (Mosk); 1968 Sep; 46(9):114-8. PubMed ID: 5715261
    [No Abstract]   [Full Text] [Related]  

  • 38. Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality.
    Monami M; Balzi D; Lamanna C; Barchielli A; Masotti G; Buiatti E; Marchionni N; Mannucci E
    Diabetes Metab Res Rev; 2007 Sep; 23(6):479-84. PubMed ID: 17385195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial with tolazamide, a new hypoglycemia agent; its potency compared to chlorpropamide.
    Quismorio FT; Villadolid LS; Egay LM; Wico AR; Llamas SP; Acurantes AI
    Acta Med Philipp; 1967; 3(4):261-5. PubMed ID: 6069635
    [No Abstract]   [Full Text] [Related]  

  • 40. Early glibenclamide treatment in a clinical newborn with KCNJ11 gene mutation.
    Däublin G; Lorenz-Depiereux B; Strom TM; Blankenstein O; Raile K
    Diabetes Care; 2007 Oct; 30(10):e104. PubMed ID: 17901525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.